Atul Pande insider trades

Open-market stock purchases and sales by Atul Pande, Director at Immunovant, Inc, from SEC Form 4 filings since Apr 29, 2016.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +265%.

Recent trades

DateStockTradeValue
Aug 28, 2026IMVT Immunovant, IncSold$64.9K
Aug 28, 2026IMVT Immunovant, IncBought (not open market)—
Jul 24, 2026IMVT Immunovant, IncBought (not open market)—
Jul 24, 2026IMVT Immunovant, IncSold$59.7K
Jun 26, 2026IMVT Immunovant, IncSold$57K
Jun 26, 2026IMVT Immunovant, IncBought (not open market)—
Jun 15, 2026IMVT Immunovant, IncSold$51K
Jun 15, 2026IMVT Immunovant, IncBought (not open market)—
May 20, 2026IMVT Immunovant, IncSold$192K
May 20, 2026IMVT Immunovant, IncBought (not open market)—
Apr 7, 2026IMVT Immunovant, IncBought (not open market)—
Apr 7, 2026IMVT Immunovant, IncBought (not open market)—

Companies traded

  • IMVT Immunovant, Inc: 2 buys, 9 sales, last Aug 28, 2026
  • KRTX Karuna Therapeutics, Inc: 21 sales, last Mar 18, 2024
  • SIOX Sio Gene Therapies Inc: 1 buy, last Apr 15, 2021
  • AXGT Axovant Gene Therapies Ltd: 3 buys, last Jul 8, 2020
  • AXON Axovant Sciences Ltd: other filings, last Mar 15, 2018

Get free alerts when Atul Pande files a new trade →